BOSTON RESEARCH & MANAGEMENT INC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001259261
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2025 · 117 positions · Total reported value $423.31M · Top-10 concentration 29.1% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 32.3% · 3 new · 34 cut · 3 exited
Active Share (vs S&P 500): 67.5% · vs QQQ: 77.4% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.7% · Prev Value $452.63M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +4.9% · vs SPY +2.8% · Latest Value $453.36M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2025 13F filing, BOSTON RESEARCH & MANAGEMENT INC disclosed 117 equity positions with a combined reported value of $423.31M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 29.1% of reported value. HoldingsHub classifies the profile as Small / High Turnover.
The largest disclosed positions as of Q2 2025 were MSFT ($20.64M), IVV ($18.39M), WMT ($12.66M). By sector, the heaviest allocations are Consumer Discretionary 25.4%, Technology 14.2%. Versus the prior quarter, allocation shifted toward Technology (+1.6pp) and away from Other (-0.5pp), Health Care (-0.7pp).
Versus the prior quarter, BOSTON RESEARCH & MANAGEMENT INC opened 3 new positions, trimmed 34 and fully exited 3, a turnover rate of 32.3% of positions. The portfolio's overlap with the prior quarter was 93% of names.
The largest new positions opened in Q2 2025 were GEV ($317.49K), WOR ($222.74K), TXN ($220.08K).
Of the 3 positions fully exited versus the prior quarter, the largest were YUMC ($224.90K), AFL ($209.04K), WEC ($207.28K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2025)
- GEV GE VERNOVA INC · $317.49K
- WOR WORTHINGTON ENTERPRISES INC · $222.74K
- TXN TEXAS INSTRS INC · $220.08K
- GS GOLDMAN SACHS GROUP INC · $212.32K
Insider Transactions (Form 4)
Latest BOSTON RESEARCH & MANAGEMENT INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Boston Research & Management is an SEC-registered 13F filer based in Manchester, MA, United States. As of Q2 2026 it reported 121 US equity positions with a combined value of $452.63M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: MANCHESTER, MA, United States
- SEC registration: 801-39603 (status: Approved), registered 1991-07-31
- Regulatory AUM (Form ADV): $676.19M as of 2026-03-25
- Client mix (by RAUM): individual investors 100%, pension and profit-sharing plans 0%
- Website: bostonrm.com
Portfolio Structure
- 121 positions · $452.63M reported value (Q2 2026)
- Top 10 holdings = 29.9% of reported value
- Largest position: IVV (ISHARES TR) at 4.8%
- Average position size: $3.74M
Sector Tilt
- Consumer Discretionary 22.4%
- Information Technology 13.6%
- Health Care 10.6%
- (classified holdings cover 78% of value)
Quarterly Activity
- Q2 2026: 6 new, 10 added, 39 reduced
- 66 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
41.50K | $20.64M | 4.88% | Reduce | |
| 2 |
|
29.62K | $18.39M | 4.34% | Reduce | |
| 3 |
|
129.46K | $12.66M | 2.99% | Reduce | |
| 4 |
|
57.44K | $11.79M | 2.78% | Add | |
| 5 |
|
20.52K | $11.53M | 2.72% | Reduce | |
| 6 |
|
35.09K | $10.17M | 2.40% | Reduce | |
| 7 |
|
145.13K | $10.07M | 2.38% | Reduce | |
| 8 |
|
51.29K | $9.52M | 2.25% | Hold | |
| 9 |
|
176.58K | $9.32M | 2.20% | Add | |
| 10 |
|
19.00K | $9.23M | 2.18% | Reduce | |
| 11 |
|
52.11K | $9.18M | 2.17% | Reduce | |
| 12 |
|
211.80K | $8.90M | 2.10% | Add | |
| 13 |
|
64.95K | $8.40M | 1.99% | Reduce | |
| 14 |
|
76.26K | $8.33M | 1.97% | Add | |
| 15 |
|
58.70K | $7.98M | 1.89% | Reduce | |
| 16 |
|
86.69K | $7.90M | 1.87% | Reduce | |
| 17 |
|
34.88K | $7.65M | 1.81% | Add | |
| 18 |
|
15.92K | $7.47M | 1.76% | Hold | |
| 19 |
|
25.15K | $7.35M | 1.74% | Hold | |
| 20 |
|
44.98K | $7.17M | 1.69% | Add | |
| 21 |
|
107.18K | $6.43M | 1.52% | Add | |
| 22 |
|
24.22K | $6.36M | 1.50% | Reduce | |
| 23 |
|
39.38K | $6.22M | 1.47% | Hold | |
| 24 |
|
54.77K | $5.90M | 1.40% | Add | |
| 25 |
|
18.97K | $5.90M | 1.39% | Add | |
| 26 |
|
70.67K | $5.90M | 1.39% | Add | |
| 27 |
|
113.80K | $5.90M | 1.39% | Add | |
| 28 |
|
46.48K | $5.76M | 1.36% | Hold | |
| 29 |
|
63.25K | $5.75M | 1.36% | Reduce | |
| 30 |
|
19.14K | $5.72M | 1.35% | Add | |
| 31 |
|
42.52K | $5.48M | 1.29% | Add | |
| 32 |
|
45.76K | $5.40M | 1.28% | Add | |
| 33 |
|
75.98K | $5.38M | 1.27% | Reduce | |
| 34 |
|
67.62K | $5.35M | 1.26% | Add | |
| 35 |
|
76.92K | $5.34M | 1.26% | Add | |
| 36 |
|
11.53K | $5.34M | 1.26% | Add | |
| 37 |
|
68.31K | $5.17M | 1.22% | Add | |
| 38 |
|
137.62K | $4.91M | 1.16% | Add | |
| 39 |
|
36.58K | $4.83M | 1.14% | Add | |
| 40 |
|
107.96K | $4.67M | 1.10% | Add | |
| 41 |
|
11.94K | $4.62M | 1.09% | Add | |
| 42 |
|
20.98K | $4.53M | 1.07% | Hold | |
| 43 |
|
20.27K | $4.52M | 1.07% | Hold | |
| 44 |
|
10.98K | $4.45M | 1.05% | Add | |
| 45 |
|
98.04K | $4.44M | 1.05% | Add | |
| 46 |
|
50.63K | $4.41M | 1.04% | Add | |
| 47 |
|
7.09K | $4.38M | 1.04% | Hold | |
| 48 |
|
42.74K | $4.31M | 1.02% | Add | |
| 49 |
|
121.96K | $3.91M | 0.93% | Add | |
| 50 |
|
44.55K | $3.78M | 0.89% | Reduce | |
FAQ
What did BOSTON RESEARCH & MANAGEMENT INC buy in 2025-Q2?
In its 2025-Q2 13F filing, BOSTON RESEARCH & MANAGEMENT INC reported 117 equity positions worth $423.31M in aggregate; its largest disclosed positions were MSFT ($20.64M), IVV ($18.39M), WMT ($12.66M).
How large is BOSTON RESEARCH & MANAGEMENT INC's portfolio?
BOSTON RESEARCH & MANAGEMENT INC reported $423.31M of long equity holdings across 117 positions as of 2025-Q2. Top-10 holdings account for 29.1% of reported value.
What is BOSTON RESEARCH & MANAGEMENT INC's investment style?
HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.